메뉴 건너뛰기




Volumn 5, Issue 2, 2010, Pages

Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; INTERLEUKIN 6; STAT5 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

EID: 77949502475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009246     Document Type: Article
Times cited : (43)

References (65)
  • 1
    • 52649083791 scopus 로고    scopus 로고
    • Epoetin alfa and darbepoetin alfa: Effects on ventricular hypertrophy in patients with chronic kidney disease
    • Chen HH, Tarng DC, Lee KF, Wu CY, Chen YC (2008) Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease. J Nephrol 21: 543-549.
    • (2008) J Nephrol , vol.21 , pp. 543-549
    • Chen, H.H.1    Tarng, D.C.2    Lee, K.F.3    Wu, C.Y.4    Chen, Y.C.5
  • 2
  • 3
    • 33645470185 scopus 로고    scopus 로고
    • Update on erythropoietin treatment: Should hemoglobin be normalized in patients with chronic kidney disease?
    • Paoletti E, Cannella G (2006) Update on erythropoietin treatment: should hemoglobin be normalized in patients with chronic kidney disease? J Am Soc Nephrol 17: S74-77.
    • (2006) J Am Soc Nephrol , vol.17
    • Paoletti, E.1    Cannella, G.2
  • 4
    • 33845641241 scopus 로고    scopus 로고
    • Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
    • Rev. CD003967
    • Strippoli GF, Navaneethan SD, Craig JC (2006) Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease. Cochrane Database Syst Rev. CD003967.
    • (2006) Cochrane Database Syst
    • Strippoli, G.F.1    Navaneethan, S.D.2    Craig, J.C.3
  • 5
    • 44649160130 scopus 로고    scopus 로고
    • From anemia trials to clinical practice: Understanding the risks and benefits when setting goals for therapy
    • Coyne DW (2008) From anemia trials to clinical practice: understanding the risks and benefits when setting goals for therapy. Semin Dial 21: 212-216.
    • (2008) Semin Dial , vol.21 , pp. 212-216
    • Coyne, D.W.1
  • 6
    • 33751002326 scopus 로고    scopus 로고
    • Normalization of hemoglobin level in patients with chronic kidney disease and anemia
    • Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, et al. (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071-2084.
    • (2006) N Engl J Med , vol.355 , pp. 2071-2084
    • Drueke, T.B.1    Locatelli, F.2    Clyne, N.3    Eckardt, K.U.4    Macdougall, I.C.5
  • 7
    • 33750983605 scopus 로고    scopus 로고
    • Correction of anemia with epoetin alfa in chronic kidney disease
    • Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, et al. (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085-2098.
    • (2006) N Engl J Med , vol.355 , pp. 2085-2098
    • Singh, A.K.1    Szczech, L.2    Tang, K.L.3    Barnhart, H.4    Sapp, S.5
  • 8
    • 0032572913 scopus 로고    scopus 로고
    • The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
    • Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, et al. (1998) The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339: 584-590.
    • (1998) N Engl J Med , vol.339 , pp. 584-590
    • Besarab, A.1    Bolton, W.K.2    Browne, J.K.3    Egrie, J.C.4    Nissenson, A.R.5
  • 10
    • 0036315869 scopus 로고    scopus 로고
    • Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; links to inflammation and oxidative stress
    • Stenvinkel P, Barany P (2002) Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; links to inflammation and oxidative stress. Nephrol Dial Transplant 17 Suppl 5: 32-37.
    • (2002) Nephrol Dial Transplant , vol.17 , Issue.SUPPL. 5 , pp. 32-37
    • Stenvinkel, P.1    Barany, P.2
  • 11
    • 33746265282 scopus 로고    scopus 로고
    • Erythropoietin resistance in the treatment of the anemia of chronic renal failure
    • Priyadarshi A, Shapiro JI (2006) Erythropoietin resistance in the treatment of the anemia of chronic renal failure. Semin Dial 19: 273-278.
    • (2006) Semin Dial , vol.19 , pp. 273-278
    • Priyadarshi, A.1    Shapiro, J.I.2
  • 12
    • 33947192111 scopus 로고    scopus 로고
    • Erythropoietin and iron-restricted erythropoiesis
    • Goodnough LT (2007) Erythropoietin and iron-restricted erythropoiesis. Exp Hematol 35: 167-172.
    • (2007) Exp Hematol , vol.35 , pp. 167-172
    • Goodnough, L.T.1
  • 13
    • 44349147141 scopus 로고    scopus 로고
    • Serum prohepcidin as an indicator of iron status in dialysis patients
    • Tsuchihashi D, Abe T, Komaba H, Fujii H, Hamada Y, et al. (2008) Serum prohepcidin as an indicator of iron status in dialysis patients. Ther Apher Dial 12: 226-231.
    • (2008) Ther Apher Dial , vol.12 , pp. 226-231
    • Tsuchihashi, D.1    Abe, T.2    Komaba, H.3    Fujii, H.4    Hamada, Y.5
  • 14
    • 36249027662 scopus 로고    scopus 로고
    • Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients
    • Kato A, Tsuji T, Luo J, Sakao Y, Yasuda H, et al. (2008) Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients. Am J Nephrol 28: 115-121.
    • (2008) Am J Nephrol , vol.28 , pp. 115-121
    • Kato, A.1    Tsuji, T.2    Luo, J.3    Sakao, Y.4    Yasuda, H.5
  • 16
    • 0035990783 scopus 로고    scopus 로고
    • Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patients
    • Tarng DC, Huang TP (2002) Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patients. Nephrol Dial Transplant 17: 1063-1069.
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 1063-1069
    • Tarng, D.C.1    Huang, T.P.2
  • 17
    • 0030846076 scopus 로고    scopus 로고
    • Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure
    • Ahluwalia N, Skikne BS, Savin V, Chonko A (1997) Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure. Am J Kidney Dis 30: 532-541.
    • (1997) Am J Kidney Dis , vol.30 , pp. 532-541
    • Ahluwalia, N.1    Skikne, B.S.2    Savin, V.3    Chonko, A.4
  • 18
    • 0032871954 scopus 로고    scopus 로고
    • Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients
    • Daschner M, Mehls O, Schaefer F (1999) Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients. Clin Nephrol 52: 246-252.
    • (1999) Clin Nephrol , vol.52 , pp. 246-252
    • Daschner, M.1    Mehls, O.2    Schaefer, F.3
  • 19
    • 0036847340 scopus 로고    scopus 로고
    • Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients
    • Chiang WC, Tsai TJ, Chen YM, Lin SL, Hsieh BS (2002) Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients. Clin Nephrol 58: 363-369.
    • (2002) Clin Nephrol , vol.58 , pp. 363-369
    • Chiang, W.C.1    Tsai, T.J.2    Chen, Y.M.3    Lin, S.L.4    Hsieh, B.S.5
  • 20
    • 0025328797 scopus 로고
    • The gene for the human erythropoietin receptor: Analysis of the coding sequence and assignment to chromosome 19p
    • Winkelmann JC, Penny LA, Deaven LL, Forget BG, Jenkins RB (1990) The gene for the human erythropoietin receptor: analysis of the coding sequence and assignment to chromosome 19p. Blood 76: 24-30.
    • (1990) Blood , vol.76 , pp. 24-30
    • Winkelmann, J.C.1    Penny, L.A.2    Deaven, L.L.3    Forget, B.G.4    Jenkins, R.B.5
  • 21
    • 0025337049 scopus 로고
    • Human erythropoietin receptor: Cloning, expression, and biologic characterization
    • Jones SS, D'Andrea AD, Haines LL, Wong GG (1990) Human erythropoietin receptor: cloning, expression, and biologic characterization. Blood 76: 31-35.
    • (1990) Blood , vol.76 , pp. 31-35
    • Jones, S.S.1    D'Andrea, A.D.2    Haines, L.L.3    Wong, G.G.4
  • 22
    • 20844450249 scopus 로고    scopus 로고
    • Erythropoietin receptors: Their role beyond erythropoiesis
    • Rossert J, Eckardt KU (2005) Erythropoietin receptors: their role beyond erythropoiesis. Nephrol Dial Transplant 20: 1025-1028.
    • (2005) Nephrol Dial Transplant , vol.20 , pp. 1025-1028
    • Rossert, J.1    Eckardt, K.U.2
  • 23
    • 0028017559 scopus 로고
    • Alternatively spliced mRNAs encoding soluble isoforms of the erythropoietin receptor in murine cell lines and bone marrow
    • Barron C, Migliaccio AR, Migliaccio G, Jiang Y, Adamson JW, et al. (1994) Alternatively spliced mRNAs encoding soluble isoforms of the erythropoietin receptor in murine cell lines and bone marrow. Gene 147: 263-268.
    • (1994) Gene , vol.147 , pp. 263-268
    • Barron, C.1    Migliaccio, A.R.2    Migliaccio, G.3    Jiang, Y.4    Adamson, J.W.5
  • 24
    • 0025942082 scopus 로고
    • Isolation of a cDNA encoding a potential soluble receptor for human erythropoietin
    • Todokoro K, Kuramochi S, Nagasawa T, Abe T, Ikawa Y (1991) Isolation of a cDNA encoding a potential soluble receptor for human erythropoietin. Gene 106: 283-284.
    • (1991) Gene , vol.106 , pp. 283-284
    • Todokoro, K.1    Kuramochi, S.2    Nagasawa, T.3    Abe, T.4    Ikawa, Y.5
  • 25
    • 0027436101 scopus 로고
    • Serum form of the erythropoietin receptor identified by a sequence-specific peptide antibody
    • Baynes RD, Reddy GK, Shih YJ, Skikne BS, Cook JD (1993) Serum form of the erythropoietin receptor identified by a sequence-specific peptide antibody. Blood 82: 2088-2095.
    • (1993) Blood , vol.82 , pp. 2088-2095
    • Baynes, R.D.1    Reddy, G.K.2    Shih, Y.J.3    Skikne, B.S.4    Cook, J.D.5
  • 26
    • 0036019540 scopus 로고    scopus 로고
    • Detection and quantification of the soluble form of the human erythropoietin receptor (sEpoR) in the growth medium of tumor cell lines and in the plasma of blood samples
    • Westphal G, Braun K, Debus J (2002) Detection and quantification of the soluble form of the human erythropoietin receptor (sEpoR) in the growth medium of tumor cell lines and in the plasma of blood samples. Clin Exp Med 2: 45-52.
    • (2002) Clin Exp Med , vol.2 , pp. 45-52
    • Westphal, G.1    Braun, K.2    Debus, J.3
  • 27
    • 0029914394 scopus 로고    scopus 로고
    • Enzyme-linked immunosorbent assay detects a potential soluble form of the erythropoietin receptor in human plasma
    • Harris KW, Winkelmann JC (1996) Enzyme-linked immunosorbent assay detects a potential soluble form of the erythropoietin receptor in human plasma. Am J Hematol 52: 8-13.
    • (1996) Am J Hematol , vol.52 , pp. 8-13
    • Harris, K.W.1    Winkelmann, J.C.2
  • 28
    • 0029976868 scopus 로고    scopus 로고
    • Lack of relationship between soluble erythropoietin receptor levels and erythroid parameters in anemic patients
    • Yoshida S, Bessho M, Sakate K, Hirasawa I, Murayoshi M, et al. (1996) Lack of relationship between soluble erythropoietin receptor levels and erythroid parameters in anemic patients. Blood 88: 3246-3247.
    • (1996) Blood , vol.88 , pp. 3246-3247
    • Yoshida, S.1    Bessho, M.2    Sakate, K.3    Hirasawa, I.4    Murayoshi, M.5
  • 29
    • 0037767746 scopus 로고    scopus 로고
    • Expression of erythropoietin receptor splice variants in human cancer
    • Arcasoy MO, Jiang X, Haroon ZA (2003) Expression of erythropoietin receptor splice variants in human cancer. Biochem Biophys Res Commun 307: 999-1007.
    • (2003) Biochem Biophys Res Commun , vol.307 , pp. 999-1007
    • Arcasoy, M.O.1    Jiang, X.2    Haroon, Z.A.3
  • 30
    • 34547851589 scopus 로고    scopus 로고
    • Soluble erythropoietin receptor is present in the mouse brain and is required for the ventilatory acclimatization to hypoxia
    • Soliz J, Gassmann M, Joseph V (2007) Soluble erythropoietin receptor is present in the mouse brain and is required for the ventilatory acclimatization to hypoxia. J Physiol 583: 329-336.
    • (2007) J Physiol , vol.583 , pp. 329-336
    • Soliz, J.1    Gassmann, M.2    Joseph, V.3
  • 31
    • 0027481011 scopus 로고
    • Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus
    • Ferro FE Jr, Kozak SL, Hoatlin ME, Kabat D (1993) Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus. J Biol Chem 268: 5741-5747.
    • (1993) J Biol Chem , vol.268 , pp. 5741-5747
    • Ferro Jr, F.E.1    Kozak, S.L.2    Hoatlin, M.E.3    Kabat, D.4
  • 32
    • 0037373006 scopus 로고    scopus 로고
    • Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
    • Maynard SE, Min JY, Merchan J, Lim KH, Li J, et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658.
    • (2003) J Clin Invest , vol.111 , pp. 649-658
    • Maynard, S.E.1    Min, J.Y.2    Merchan, J.3    Lim, K.H.4    Li, J.5
  • 33
    • 33744985816 scopus 로고    scopus 로고
    • Soluble endoglin contributes to the pathogenesis of preeclampsia
    • Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, et al. (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12: 642-649.
    • (2006) Nat Med , vol.12 , pp. 642-649
    • Venkatesha, S.1    Toporsian, M.2    Lam, C.3    Hanai, J.4    Mammoto, T.5
  • 34
    • 0027281793 scopus 로고
    • The extracytoplasmic domain of the erythropoietin receptor forms a monomeric complex with erythropoietin
    • Yet MG, Jones SS (1993) The extracytoplasmic domain of the erythropoietin receptor forms a monomeric complex with erythropoietin. Blood 82: 1713-1719.
    • (1993) Blood , vol.82 , pp. 1713-1719
    • Yet, M.G.1    Jones, S.S.2
  • 35
    • 3042794598 scopus 로고    scopus 로고
    • Erythropoietin regulation of Raf-1 and MEK: Evidence for a Ras-independent mechanism
    • Chen C, Sytkowski AJ (2004) Erythropoietin regulation of Raf-1 and MEK: evidence for a Ras-independent mechanism. Blood 104: 73-80.
    • (2004) Blood , vol.104 , pp. 73-80
    • Chen, C.1    Sytkowski, A.J.2
  • 36
    • 0035914336 scopus 로고    scopus 로고
    • Erythropoietin activates two distinct signaling pathways required for the initiation and the elongation of c-myc
    • Chen C, Sytkowski AJ (2001) Erythropoietin activates two distinct signaling pathways required for the initiation and the elongation of c-myc. J Biol Chem 276: 38518-38526.
    • (2001) J Biol Chem , vol.276 , pp. 38518-38526
    • Chen, C.1    Sytkowski, A.J.2
  • 37
    • 49249104701 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
    • Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, et al. (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359: 584-592.
    • (2008) N Engl J Med , vol.359 , pp. 584-592
    • Gutierrez, O.M.1    Mannstadt, M.2    Isakova, T.3    Rauh-Hain, J.A.4    Tamez, H.5
  • 38
    • 65649103459 scopus 로고    scopus 로고
    • Plasma gelsolin and circulating actin correlate with hemodialysis mortality
    • Lee PS, Sampath K, Karumanchi SA, Tamez H, Bhan I, et al. (2009) Plasma gelsolin and circulating actin correlate with hemodialysis mortality. J Am Soc Nephrol 20: 1140-1148.
    • (2009) J Am Soc Nephrol , vol.20 , pp. 1140-1148
    • Lee, P.S.1    Sampath, K.2    Karumanchi, S.A.3    Tamez, H.4    Bhan, I.5
  • 39
    • 34948869354 scopus 로고    scopus 로고
    • Vitamin D levels and early mortality among incident hemodialysis patients
    • Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, et al. (2007) Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72: 1004-1013.
    • (2007) Kidney Int , vol.72 , pp. 1004-1013
    • Wolf, M.1    Shah, A.2    Gutierrez, O.3    Ankers, E.4    Monroy, M.5
  • 40
    • 48149102507 scopus 로고    scopus 로고
    • Impact of activated vitamin D and race on survival among hemodialysis patients
    • Wolf M, Betancourt J, Chang Y, Shah A, Teng M, et al. (2008) Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 19: 1379-1388.
    • (2008) J Am Soc Nephrol , vol.19 , pp. 1379-1388
    • Wolf, M.1    Betancourt, J.2    Chang, Y.3    Shah, A.4    Teng, M.5
  • 41
    • 58149352646 scopus 로고    scopus 로고
    • Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients
    • Brunelli SM, Lynch KE, Ankers ED, Joffe MM, Yang W, et al. (2008) Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients. Clin J Am Soc Nephrol 3: 1733-1740.
    • (2008) Clin J Am Soc Nephrol , vol.3 , pp. 1733-1740
    • Brunelli, S.M.1    Lynch, K.E.2    Ankers, E.D.3    Joffe, M.M.4    Yang, W.5
  • 42
    • 60149091852 scopus 로고    scopus 로고
    • Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients
    • Kalantar-Zadeh K, Lee GH, Miller JE, Streja E, Jing J, et al. (2009) Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Am J Kidney Dis 53: 823-834.
    • (2009) Am J Kidney Dis , vol.53 , pp. 823-834
    • Kalantar-Zadeh, K.1    Lee, G.H.2    Miller, J.E.3    Streja, E.4    Jing, J.5
  • 44
    • 56049125423 scopus 로고    scopus 로고
    • The association of race with erythropoietin dose in patients on long-term hemodialysis
    • Lacson E Jr, Rogus J, Teng M, Lazarus JM, Hakim RM (2008) The association of race with erythropoietin dose in patients on long-term hemodialysis. Am J Kidney Dis 52: 1104-1114.
    • (2008) Am J Kidney Dis , vol.52 , pp. 1104-1114
    • Lacson Jr, E.1    Rogus, J.2    Teng, M.3    Lazarus, J.M.4    Hakim, R.M.5
  • 45
    • 3042725549 scopus 로고    scopus 로고
    • Derivatives of erythropoietin that are tissue protective but not erythropoietic
    • Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, et al. (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305: 239-242.
    • (2004) Science , vol.305 , pp. 239-242
    • Leist, M.1    Ghezzi, P.2    Grasso, G.3    Bianchi, R.4    Villa, P.5
  • 46
    • 0029998539 scopus 로고    scopus 로고
    • Interleukin-3 (IL-3) inhibits erythropoietin-induced differentiation in Ba/F3 cells via the IL-3 receptor alpha subunit
    • Krosl J, Damen JE, Krystal G, Humphries RK (1996) Interleukin-3 (IL-3) inhibits erythropoietin-induced differentiation in Ba/F3 cells via the IL-3 receptor alpha subunit. J Biol Chem 271: 27432-27437.
    • (1996) J Biol Chem , vol.271 , pp. 27432-27437
    • Krosl, J.1    Damen, J.E.2    Krystal, G.3    Humphries, R.K.4
  • 47
    • 50849121381 scopus 로고    scopus 로고
    • Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease
    • Keithi-Reddy SR, Addabbo F, Patel TV, Mittal BV, Goligorsky MS, et al. (2008) Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease. Kidney Int 74: 782-790.
    • (2008) Kidney Int , vol.74 , pp. 782-790
    • Keithi-Reddy, S.R.1    Addabbo, F.2    Patel, T.V.3    Mittal, B.V.4    Goligorsky, M.S.5
  • 48
    • 0016640079 scopus 로고
    • Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome
    • Lozzio CB, Lozzio BB (1975) Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45: 321-334.
    • (1975) Blood , vol.45 , pp. 321-334
    • Lozzio, C.B.1    Lozzio, B.B.2
  • 49
    • 0035887309 scopus 로고    scopus 로고
    • Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase
    • Kubota Y, Tanaka T, Kitanaka A, Ohnishi H, Okutani Y, et al. (2001) Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase. EMBO J 20: 5666-5677.
    • (2001) EMBO J , vol.20 , pp. 5666-5677
    • Kubota, Y.1    Tanaka, T.2    Kitanaka, A.3    Ohnishi, H.4    Okutani, Y.5
  • 50
    • 0034007818 scopus 로고    scopus 로고
    • Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids
    • Hornig C, Barleon B, Ahmad S, Vuorela P, Ahmed A, et al. (2000) Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest 80: 443-454.
    • (2000) Lab Invest , vol.80 , pp. 443-454
    • Hornig, C.1    Barleon, B.2    Ahmad, S.3    Vuorela, P.4    Ahmed, A.5
  • 52
    • 4644317542 scopus 로고    scopus 로고
    • Postsecretion neutralization of transgene-derived effect: Soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle
    • Maruyama H, Higuchi M, Higuchi N, Kameda S, Saito M, et al. (2004) Postsecretion neutralization of transgene-derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle. J Gene Med 6: 228-237.
    • (2004) J Gene Med , vol.6 , pp. 228-237
    • Maruyama, H.1    Higuchi, M.2    Higuchi, N.3    Kameda, S.4    Saito, M.5
  • 53
    • 0026442116 scopus 로고
    • Production and ligand-binding characteristics of the soluble form of murine erythropoietin receptor
    • Nagao M, Masuda S, Abe S, Ueda M, Sasaki R (1992) Production and ligand-binding characteristics of the soluble form of murine erythropoietin receptor. Biochem Biophys Res Commun 188: 888-897.
    • (1992) Biochem Biophys Res Commun , vol.188 , pp. 888-897
    • Nagao, M.1    Masuda, S.2    Abe, S.3    Ueda, M.4    Sasaki, R.5
  • 54
    • 11244333356 scopus 로고    scopus 로고
    • New avenues of exploration for erythropoietin
    • Maiese K, Li F, Chong ZZ (2005) New avenues of exploration for erythropoietin. JAMA 293: 90-95.
    • (2005) JAMA , vol.293 , pp. 90-95
    • Maiese, K.1    Li, F.2    Chong, Z.Z.3
  • 55
    • 54049113367 scopus 로고    scopus 로고
    • Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation
    • Buck I, Morceau F, Cristofanon S, Heintz C, Chateauvieux S, et al. (2008) Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation. Biochem Pharmacol 76: 1229-1239.
    • (2008) Biochem Pharmacol , vol.76 , pp. 1229-1239
    • Buck, I.1    Morceau, F.2    Cristofanon, S.3    Heintz, C.4    Chateauvieux, S.5
  • 56
    • 36348966705 scopus 로고    scopus 로고
    • Cellular protection by erythropoietin: New therapeutic implications?
    • Joyeux-Faure M (2007) Cellular protection by erythropoietin: new therapeutic implications? J Pharmacol Exp Ther 323: 759-762.
    • (2007) J Pharmacol Exp Ther , vol.323 , pp. 759-762
    • Joyeux-Faure, M.1
  • 57
    • 4644310308 scopus 로고    scopus 로고
    • Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells
    • Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, et al. (2004) Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 104: 2073-2080.
    • (2004) Blood , vol.104 , pp. 2073-2080
    • Beleslin-Cokic, B.B.1    Cokic, V.P.2    Yu, X.3    Weksler, B.B.4    Schechter, A.N.5
  • 58
    • 0027620152 scopus 로고
    • Endocytosis of growth factor receptors
    • Sorkin A, Waters CM (1993) Endocytosis of growth factor receptors. Bioessays 15: 375-382.
    • (1993) Bioessays , vol.15 , pp. 375-382
    • Sorkin, A.1    Waters, C.M.2
  • 59
    • 0030030714 scopus 로고    scopus 로고
    • Blocking intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the same increase in the levels of their membrane and secreted forms
    • Neumann D, Yuk MH, Lodish HF, Lederkremer GZ (1996) Blocking intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the same increase in the levels of their membrane and secreted forms. Biochem J 313 (Pt 2): 391-399.
    • (1996) Biochem J , vol.313 , Issue.PART 2 , pp. 391-399
    • Neumann, D.1    Yuk, M.H.2    Lodish, H.F.3    Lederkremer, G.Z.4
  • 61
    • 0036408985 scopus 로고    scopus 로고
    • Non-erythropoietin-based anaemia management in chronic kidney disease
    • Horl WH (2002) Non-erythropoietin-based anaemia management in chronic kidney disease. Nephrol Dial Transplant 17 Suppl 11: 35-38.
    • (2002) Nephrol Dial Transplant , vol.17 , Issue.SUPPL. 11 , pp. 35-38
    • Horl, W.H.1
  • 62
    • 0142231519 scopus 로고    scopus 로고
    • Erythropoeitin dose variation in different facilities in different countries and its relationship to drug resistance
    • Greenwood RN, Ronco C, Gastaldon F, Brendolan A, Homel P, et al. (2003) Erythropoeitin dose variation in different facilities in different countries and its relationship to drug resistance. Kidney Int Suppl. S78-86.
    • (2003) Kidney Int Suppl
    • Greenwood, R.N.1    Ronco, C.2    Gastaldon, F.3    Brendolan, A.4    Homel, P.5
  • 63
    • 3042772186 scopus 로고    scopus 로고
    • Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
    • Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, et al. (2004) Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 44: 94-111.
    • (2004) Am J Kidney Dis , vol.44 , pp. 94-111
    • Pisoni, R.L.1    Bragg-Gresham, J.L.2    Young, E.W.3    Akizawa, T.4    Asano, Y.5
  • 64
    • 40349103260 scopus 로고    scopus 로고
    • Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
    • Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, et al. (2008) Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 299: 914-924.
    • (2008) JAMA , vol.299 , pp. 914-924
    • Bennett, C.L.1    Silver, S.M.2    Djulbegovic, B.3    Samaras, A.T.4    Blau, C.A.5
  • 65
    • 14744278436 scopus 로고    scopus 로고
    • Anemia of chronic disease
    • Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352: 1011-1023.
    • (2005) N Engl J Med , vol.352 , pp. 1011-1023
    • Weiss, G.1    Goodnough, L.T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.